These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


697 related items for PubMed ID: 16735938

  • 1. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA.
    Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
    [Abstract] [Full Text] [Related]

  • 2. Hot flashes and estrogen therapy do not influence cognition in early menopausal women.
    LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS.
    Menopause; 2007; 14(2):191-202. PubMed ID: 17194963
    [Abstract] [Full Text] [Related]

  • 3. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [Abstract] [Full Text] [Related]

  • 4. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women.
    Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A.
    Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602
    [Abstract] [Full Text] [Related]

  • 5. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women.
    Krug R, Born J, Rasch B.
    Psychoneuroendocrinology; 2006 Sep; 31(8):965-75. PubMed ID: 16831520
    [Abstract] [Full Text] [Related]

  • 6. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 8. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 9. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S, Bell RJ, Savage G, Goldstat R, Papalia MA, Kulkarni J, Donath S, Davis SR.
    Menopause; 2006 Oct 20; 13(4):600-8. PubMed ID: 16837882
    [Abstract] [Full Text] [Related]

  • 10. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 20; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 11. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
    Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D.
    Arch Neurol; 2006 Jul 20; 63(7):945-50. PubMed ID: 16831962
    [Abstract] [Full Text] [Related]

  • 12. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L.
    Neurobiol Aging; 2006 Jan 20; 27(1):141-9. PubMed ID: 16298249
    [Abstract] [Full Text] [Related]

  • 13. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec 20; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 14. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul 20; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Jul 20; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 17. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 May 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 18. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.
    Menopause; 2007 May 20; 14(4):648-55. PubMed ID: 17251874
    [Abstract] [Full Text] [Related]

  • 19. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
    Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K.
    Neurology; 2007 Sep 25; 69(13):1322-30. PubMed ID: 17893293
    [Abstract] [Full Text] [Related]

  • 20. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Sep 25; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.